Oscar Health, Inc. (OSCR)

Oscar Health Stock Forecast

Stock Price Forecast

The 7 analysts that cover Oscar Health stock have a consensus rating of "Sell" and an average price target of $12.64, which forecasts a -42.02% decrease in the stock price over the next year. The lowest target is $11 and the highest is $14.

Price Target: $12.64 (-42.02%)

Analyst Consensus: Sell

Target	Low	Average	Median	High
Price	$11	$12.64	$13	$14
Change	-49.54%	-42.02%	-40.37%	-35.78%

Analyst Ratings

The average analyst rating for Oscar Health stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

Rating	May '25	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25
Strong Buy	0	0	0	0	0	0
Buy	3	1	1	0	0	0
Hold	3	2	1	2	2	2
Sell	2	2	4	4	4	4
Strong Sell	0	0	1	1	1	1
Total	8	5	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Stephen Baxter Wells Fargo	Wells Fargo	Sell Maintains $10 → $14	Sell	Maintains	$10 → $14	-35.78%	Oct 7, 2025
Jessica Tassan Piper Sandler	Piper Sandler	Hold Maintains $14 → $13	Hold	Maintains	$14 → $13	-40.37%	Aug 14, 2025
Michael Ha Baird	Baird	Buy → Hold Downgrades $28 → $14	Buy → Hold	Downgrades	$28 → $14	-35.78%	Jul 25, 2025
Andrew Mok Barclays	Barclays	Sell Maintains $17 → $11	Sell	Maintains	$17 → $11	-49.54%	Jul 23, 2025
Jonathan Yong UBS	UBS	Hold → Strong Sell Downgrades $15 → $11	Hold → Strong Sell	Downgrades	$15 → $11	-49.54%	Jul 15, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

12.30B

Increased by 33.98%

from 9.18B

Revenue Next Year

11.53B

Decreased by -6.26%

from 12.30B

EPS This Year

-1.37

from 0.10

EPS Next Year

-0.42

from -1.37

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	390.99M	1.89B	3.96B	5.86B	9.18B	12.30B	11.53B
Revenue Growth	-17.79%	384.43%	109.27%	47.92%	56.54%	33.98%	-6.26%
EPS	-14.16	-3.20	-2.85	-1.22	0.10	-1.37	-0.42
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	11	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	12.7B	12.7B
Avg	12.3B	11.5B
Low	11.8B	10.7B

Revenue Growth

Revenue Growth	2025	2026	2027
High	38.6%	3.6%
Avg	34.0%	-6.3%
Low	28.1%	-13.2%

EPS Forecast

EPS	2025	2026	2027
High	-1.23	0.17
Avg	-1.37	-0.42
Low	-1.44	-1.04

EPS Growth

EPS Growth	2025	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.